green maschine
1 day ago
I think you gotta be a billionaire to influence him on anything, and be willing to donate a million dollar contribution to his PAC or buy 1,000 of his $1,000 bibles (i.e. signed edition) which never get delivered, etc. So if you're going to make a few milly on TNXP upon approval, you might have his ear.
Dumb&dumber4long
2 days ago
I already did, on the naked short selling, which is Illegal, December 18th, when more than 5x the outstanding shares traded in one day.
But the reply I got back on this site, The SEC is Corrupt!
Understaffed overloaded with complaints may appear as so.
There are bigger fish to catch!
However, I have learned years agoβ
βNEVER UNDERESTIMATE THE POWER OF IDIOTS BY THE NUMBERSβ.
The same thought applies to filing complaints.
The more complaints, the many more would be better.
Dumb&dumber4long
2 days ago
I have been suffering from fibromyalgia for more than a decade.
It was tolerable at the start, being younger then.
Now, my life is miserable, truly.
I am waiting on a medicine I can tolerate.
Current meds are not for me, considering the side effects & med history.
It would be more disappointing if the FDA doesnβt approve, than the share price movement.
timberwolf7
3 days ago
Speculative with respect to biotech developments.
One more comment: one thing I am very wary of is the
problem that they are trying to 'solve' when it comes to biotechs.
Cancers, alzheimers, very low success rates in terms of actual 'results'.
Complex trials, uncertainty. So for these type of developments, they
are speculative to me until the PH 3 results are known.
Something like TNXPs? Pretty straightforward, yet subjective cause
how well can you classify 'pain'? As a volunteer EMT, we periodically
will ask a patient their 'pain' score, whether or not its getting better/worse.
But its subjective and everyone has a varying degree of resistance to pain.
My threshold is very high versus many for example.
CRMDs development: when they finished their PH 2 trial, and the results were good.
It was a gift at 23 cents/sh cause no one wanted the shares. Cause the PH3 was going
to be a repeat of the PH 2, just more folks involved. The confidence level was very high
on that one.
Kind of feel the same way here on TNXP in terms of the 'outcome' from taking the compound
is pretty straight forward. Do you 'feel' better or not? Did the pain reduce, et al. Its not an
Alzheimer development like SAVA (check out their chart and trust me when I say, there were
folks that were betting a lot that their PH 2 said they had solved ALZs, and the PH3 was going
to say the same thing (till it didn't)
So to close, biotechs ARE very speculative to a point. The question becomes one of, at
what point can you start to trust the potential for them to accomplish what they are trying to do.
And even then, you then have the fda, manufacturer involved hurdles to be met that you
can't quantify in advance (additional 'wild cards')
Ok, enough pondering on a cold, snowy, windy day.. time for a little P90x for this senior
citizen (smile) (at a reduced intensity level of course vs my youth when we would have laughed
at it being called a 'workout')
timberwolf7
3 days ago
R/S: I really don't care if they do a reverse split because to me, its all
about their MARKET CAP (shares x price) and hoping that no matter
what they do, they can justify the market cap going forward that got you
into the stock in the first place.
What I am concerned about is if they do a secondary on top of it to raise
cash for operations. For then, although the Market Cap remains a constant,
now the share price gets reduced/diluted
Had CRMD that thru no fault of their own, ended up with 2 CRLs due to quality
issues at their chosen manufacturer (note, they were CRLd over quality concerns, but
the manufacturer was allowed to keep producing other drugs they were already making/shipping)
And because of the CRLs, delays in sales, they were forced to dilute to raise cash. The
CONSERVATIVE target price I had of $27 was cut to $13-14.. So ya really don't want to see a
secondary or ATM to raise cash, but its far too common and really has the potential to hurt the returns.
And on CRMD?? I had 45,000 shares, so yeah, it 'hurt' the expectations. (disclaimer: still own some
of the shares for their sales are ramping up, they expect to go profitable. And they have some other
projects in the works that are expected to expand revenues and the target price). So my target price
now is $15-16 and looking to see what it gets after the coming qtrly report..
Good luck..
timberwolf7
3 days ago
Its not 'speculative' anymore.
They PASSED 2 of the 3 clinical trials, met the end points
and the 3rd one they say only 'failed' reportedly only because folks withdrew from the trial, but
otherwise, again, reportedly met the trial end points.
Now its possible the clinical trials aren't robust enough for the fda to accept the results and approve.
And I am only saying that because of another company that I had followed for years, passed their
clinical trial with excellent results. Only for the fda to reject the trial because the FDA changed the
acceptance criteria AFTER the trials were concluded.
And told them to modify the acceptance criteria and asked them to expand the scope of the trial itself if
they wanted approval. In the meantime, this development which HELPED people dealing with a certain
type of cancer will now be DENIED to them. MFkers at the FDA should have approved the development, let it help people and then asked for a PH 4 instead of what they did. ATNM
(Disclaimer: I had traded shares on ATNM prior to the PH 3 passing, and only had a few shares
at the time of this announcement because I hadn't reloaded yet for the decision. Yep, I was very
fortunate, but still ticked off cause those this WOULD have helped has been denied by the fricking org
that is supposed to be there to 'help' people, yet look what they did to help hurt so many people with the BS they pulled with the covid jabs that ARE/HAVE hurt so many (not to mention the deaths involved)
So given the passing of the clinical trials, this is no longer 'speculative'... They passed that phase with
the completion of the PH 3s..
timberwolf7
4 days ago
Because its in a lull period between the latest 'good news PR' and
when that PR has the potential (fda decision) to translate into revenues/earnings.
Very typical activity when the PR doesn't translate into something 'good' near term to
keep the markets attention.
But, IF you have some degree of confidence in the eventual outcome? Great time to
grab some at a price like this and park it. Have to remember, one of the KEY metrics
to monitor is the MARKET CAP.. (at $43 Mil this morn)
At this market cap, given what they are trying to 'solve' with this devlopment, 10x the current
share price is still a pretty reasonable market cap vs the potential sales.
Surely folks can have the patience for a POTENTIAL 10x return over the next 7 months...
And even if you aren't sure of the approval, its bound to run up to some level PRE-fda decision and
can be sold.
So either ya believe or you don't, and if you do, then be happy with the pullback for the chance to add..
disclaimer: own shares
Value_Investor
5 days ago
Wow, "BUY" rating (see the link below) for this Hidden Gem with $53.5 price target! I was buying TNXP all the way down from much higher price levels and I'll continue to buy all the way up until this Diamond-In-Rough hits the Dolland Land again. I'm very happy for all my purchasing price levels at $0.9xxx ~ $0.2xxx!
My goal is to accumulate 1,869,159 shares so that my position here will be worthy over $100M or $100,000,000 at the price target $53.5!
https://www.marketbeat.com/stocks/NASDAQ/TNXP/forecast/
Last evening TNXP ever bounced up to $0.3 and this early morning it bounced up to $0.2965!